Skip to main content

Table 2 Adverse events during CHP-NY-ESO-1 vaccinations

From: Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients

  100 μg(n = 13) 200 μg(n = 12) Total
Adverse event Grade Grade
  1 2 3 4 5 Subtotal 1 2 3 4 5 Subtotal
Skin reaction 12 0 0 0 0 12 12 0 0 0 0 12 24
Swallowing disturbance 0 0 3 0 0 3 0 0 4 1 0 5 8
Diarrhea 0 0 2 0 0 2 1 0 0 0 0 1 3
Fever 2 0 0 0 0 2 0 0 0 0 0 0 2
Decreased lymphocytes count 0 0 7 0 0 7 0 0 3 0 0 3 10
Decreased Na level 0 0 2 0 0 2 0 0 2 0 0 2 4
Decreased Hb level 0 0 3 0 0 3 0 0 0 0 0 0 3
Elevated ALT/AST level 0 0 2 0 0 2 0 0 0 0 0 0 2
Elevated uric acid level 0 0 1 1 0 2 0 0 0 0 0 0 2
  1. NOTE: Events occurring more than once are listed. Events of disease progression are not listed.